[Glucocorticoid for coronavirus disease 2019: a dilemma]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
.
2020 Mar;32(3):278.
doi: 10.3760/cma.j.cn121430-20200309-00352.
[Article in Chinese]
Authors
Xinxin Du
1
,
Xiangyou Yu
Affiliation
1
Department of Critical Care Medicine, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China. Corresponding author: Yu Xiangyou, Email: yu2796@163.com.
PMID:
32385989
DOI:
10.3760/cma.j.cn121430-20200309-00352
No abstract available
MeSH terms
Betacoronavirus
COVID-19
Coronavirus
Coronavirus Infections / drug therapy*
Glucocorticoids / therapeutic use*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
SARS-CoV-2
Substances
Glucocorticoids